placeholder image
D. Schiff All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Mirdametinib in symptomatic neurofibromatosis type 1 plexiform neurofibromas. 
    Expert Review of Anticancer Therapy. 2026
  • A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872. 
    Cancer. 2019
  • Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572. 
    Cancer. 2018
    • Contact
    full name
  • D. Schiff
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration